Northwell Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwell Health sits in the top decile of US sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count).

370 total trials 81 currently recruiting 209 completed early-phase tilt top decile by trial count

Northwell Health: 370 sponsored US clinical trials, 81 recruiting.

Northwell Health sponsors 370 registered US clinical trials on ClinicalTrials.gov, 81 of them currently recruiting, and 209 completed. 38 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 8 trials.

Top-decile sponsor footprint

Northwell Health ranks in the top decile of sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

209 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

370 total, page 6 of 8

COMPLETED

Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.

NCT01786369

COMPLETED

MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension

NCT02858791

COMPLETED Phase 1

Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM

NCT01811498

COMPLETED Phase 2

Robots Paired With tDCS in Stroke Recovery

NCT01726673

TERMINATED

The Role of HMGB-1 in Chronic Stroke

NCT01705353

COMPLETED

Comparison of Muscle Atrophy After Direct Anterior & Posterior Total Hip Arthroplasty

NCT01636375

COMPLETED NA

Component Analysis for Motivational Interviewing

NCT01642381

TERMINATED NA

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

NCT01590979

COMPLETED Phase 1

Effects of Auricular Vagus Nerve Stimulation on the Pro-inflammatory Cytokine Response in Healthy Adults

NCT01569789

TERMINATED Phase 1

Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia

NCT01464164

COMPLETED

The Assessment of Movement Disorders Utilizing Live Two-Way Video

NCT01467089

COMPLETED NA

Weight Loss & Comorbidity Resolution With LAGB Alone vs. LAGB With Gastric Plication

NCT01703546

TERMINATED Phase 2

Role of Topical Tranexamic Acid in Total Hip Arthroplasty

NCT01866943

COMPLETED

UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

NCT01850706

COMPLETED

Study of T-Regulatory Cells in Asthma

NCT02574351

COMPLETED

Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters

NCT01363505

COMPLETED NA

The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics

NCT01329939

TERMINATED NA

Comparison of Conservative and Aggressive Smoking Cessation Treatment Strategies in a Vascular Surgery Office Practice

NCT01850589

COMPLETED NA

Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction

NCT01734980

COMPLETED Phase 4

Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine

NCT01153490

COMPLETED

Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?

NCT01231646

COMPLETED

Impact of Sperm DNA Integrity on In Vitro Cycles

NCT01232465

TERMINATED NA

Fertility Preservation in Female Cancer Patients

NCT01268592

TERMINATED NA

Oocyte Cryopreservation

NCT01232972

COMPLETED

Effect of Hemodialysis Membranes on Platelet Count

NCT01356576

COMPLETED Phase 1

SBRT for Organ Confined Prostate Cancer

NCT02653248

COMPLETED NA

Evidence Based Decision Making: Integrating Clinical Prediction Rules

NCT01386047

COMPLETED Phase 1

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

NCT01180816

TERMINATED Phase 2

Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity

NCT01525927

COMPLETED NA

An Integrated Program for the Treatment of First Episode of Psychosis

NCT01321177

COMPLETED

Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients

NCT01865890

COMPLETED Phase 4

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

NCT01881763

COMPLETED NA

A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis

NCT01399112

COMPLETED

Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients

NCT01364779

COMPLETED NA

Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer

NCT02703493

COMPLETED

Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma

NCT01076114

COMPLETED

Ventricular Arrhythmias in Uremic Cardiomyopathy

NCT01856400

COMPLETED Phase 2

The Use of Heliox in Obstructive Sleep Apnea Syndrome

NCT02135900

COMPLETED

The Role of ITGAM in Systemic Lupus Erythematosus

NCT01230112

COMPLETED Phase 1

Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

NCT01238237

COMPLETED

Iron Overload in Pediatric Oncology Patients

NCT01034072

COMPLETED

Urine pH as a Predictor of Diabetes

NCT01017848

COMPLETED Phase 2

Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients

NCT01007994

COMPLETED NA

Aprepitant for Post-operative Nausea

NCT01020903

COMPLETED NA

Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

NCT01878513

COMPLETED Phase 1

Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)

NCT00968240

COMPLETED NA

Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients

NCT01876732

COMPLETED

Biomarkers in the Evaluation of Chronic Lung Disease

NCT00926523

COMPLETED

Pilot Study: The Role of Macrophage Migration Inhibitory Factor (MIF) in Spinal Cord Injury

NCT00919581

COMPLETED

Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways

NCT01161056

← Previous Page 6 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 30
Phase 3 12
Phase 4 26

What is open in the Northwell Health pipeline

81 recruiting of 370 indexed (22% open); 209 completed (56%).

Phase mix: 38 late (III/IV) vs 80 early (I/II) (early-phase heavy).

Top condition: Schizophrenia (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwell Health: open-pipeline peers nationwide

Peers matched on 370 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%5%10%15%20%25% Total trials Recruiting share Northwell HealthUniversity of California, IrvineUNC Lineberger Comprehensive Cancer CenterRoswell Park Cancer InstituteNew York State Psychiatric InstituteSt. Jude Children's Research HospitalRegeneron PharmaceuticalsAtriCureUniversity of Colorado, Boulder
Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 370 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

What to do with this Northwell Health page

370 registered trials is a research-attention snapshot, not an endorsement of Northwell Health or any single study.

  • 81 of Northwell Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Schizophrenia is the condition Northwell Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Northwell Health pipeline card: 370 registered trials from official public datasets.Report a data error.